Contact Us Inquiry Now
Current Language
    Change Language

    Biopharmaceutical

    Pipeline

    Healthgen Biotech focuses on plant molecular pharmaceutical technology based on rice endosperm cell specific expression platform (Oryzᴴⁱᴱˣᵖ). We are committed to supplying green, safe, accessible and sufficient biopharmaceutical products to people worldwide and improving global public health. Among our pipelines, the HY1001, Recombinant human albumin Injection(Oryza Sativa), has obtained marketing approval in China.

    Olbumin® Recombinant Human Albumin Injection (Oryza Sativa)

    As an alternative to human plasma-derived albumin, Olbumin® Recombinant Human Albumin Injection (Oryza Sativa) resolves two core pain points: constrained plasma raw material supply and infectious virus transmission risks associated with plasma preparations, offering enhanced safety and stability for global clinical application.

    • Pharmaceutical Dosage Forms： 50ml, 20%/vial(10g)
    • Indications： Hypoalbuminemia in liver cirrhosis
    Inquire Now
    Learn More

    Raw Materials

    In Life Science

    OsrHSA can be widely applied in biopharmaceutical manufacturing processes for purposes such as cell culture supplement, drug carriers, vaccine stabilizers, cell cryopreservation agents, and medical device embedding agents.

    Learn More

    Product

    Center

    View All Products

    About Us

    Healthgen Biotech

    Wuhan Healthgen Biotechnology Corp. (Healthgen Biotech), specializing in molecular pharmaceutical research and development, is a private company founded in 2006. Healthgen Biotech is a national high and new biotech enterprise. Its commission is to use a state-of-art technology, rice endosperm cell specific expression platform (Oryzᴴⁱᴱˣᵖ), with high capacity to express proteins or small peptides in the rice grain, to develop the plant-made pharmaceuticals (PMP). The PMP provides a new approach for production of biopharmaceuticals...

    Learn More

    Why

    OryzHiExp?

    It was developed by Healthgen Biotechnology utilizing its patented rice endosperm cell protein expression platform (OryzHiExp ) and is produced in a smart biopharmaceutical manufacturing facility that is automated, digitized, and intelligent—operating on a foundation of DCS and MES systems.

    • Safer

      Animal-free, No allergens and Low impurities.

    • Complete biological function

      Higher eukaryotes with complete functional units for protein Expression, folding & modification, and lower immunogenicity without additional glycosylation modifications.

    • Environmentally friendly

      Photosynthesis replaces fermentation, being more environmentally friendly.

    • High expression level

      20-30 grams of protein per kilogram of brown rice.

    • Simple production process

      Merely 1–3 purification steps yield protein purity of 95%–99%.

    • Easily scaled-up

      Large-scale rice cultivation can be easily achieved.

    News

    & Events

    Here you can learn more about Healthgen Biotechnology.

    Learn More

    TAKE THE FIRST STEP TO A PROSPEROUS FUTURE!

    To provide the people of the world with green, safe, accessible, and abundant biopharmaceutical products.

    WhatsApp

    Leave a message!

    Leave a message!
    Document